Fluoroquinolone resistance of Staphylococcus epidermidis isolated from healthy conjunctiva and analysis of their mutations in quinolone-resistance determining region

Author:

Kang Jung Youb,Lee Woonhyoung,Noh Gwang Myeong,Jeong Bo Hyun,Park Indal,Lee Sang JoonORCID

Abstract

AbstractBackgroundStaphylococcus epidermidisis the most common pathogen in postoperative endophthalmitis and causes various infectious eye diseases. However, there is very little information on fluoroquinolone antibiotic resistance toS. epidermidisidentified in conjunctival microbe and analysis of related genes. Here, the authors investigated the rate of resistance to fluoroquinolones ofStaphylococcus epidermidisisolated from normal conjunctival microbes and mutations in the quinolone-resistance determining region (QRDR).Methods377 eye samples from 187 patients who underwent intravitreal injection and cataract surgery were included. Specimens were taken from the bilateral lower conjunctival sacs using a cotton swab and cultured. The cultures were identified using MALDI-TOP MS andgyrA, gyrB, parC, andparEgene mutations of QRDR were confirmed by DNA extraction from resistant strains ofS. epidermidiswith a micro-dilution method using ciprofloxacin, levofloxacin, and moxifloxacin.ResultsThe culture positive rate was 61.8% (231) for 374 eye samples. Of the 303 total strains cultured,S. epidermidiswas the most common with 33.7% (102). Ten types of gene mutations were observed in the resistantS. epidermidisof 21 strains. One-point mutation was observed mainly ingyrAandparC, and a small number of mutations were observed inparEin the form of a double point mutations. When there were multiple point mutations in bothgyrAandparC, the highest minimum inhibitory concentration was observed.ConclusionsThe quinolone resistance rate ofS. epidermidisincreased in comparison with previous studies, and resistantS. epidermidisshowed mostly QRDR mutations, which were mainly found ingyrAandparC, and showed strong resistance when mutated in both genes.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3